| LncRNA-CCAT5-mediated crosstalk between Wnt/beta-Catenin and STAT3 signaling suggests novel therapeutic approaches for metastatic gastric cancer with high Wnt activity. | LncRNA-CCAT5-mediated crosstalk between Wnt/β-Catenin and STAT3 signaling suggests novel therapeutic approaches for metastatic gastric cancer with high Wnt activity.
Liu C, Shen A, Song J, Cheng L, Zhang M, Wang Y, Liu X., Free PMC Article | 01/29/2024 |
| Activation of MYO1G by lncRNA MNX1-AS1 Drives the Progression in Lung Cancer. | Activation of MYO1G by lncRNA MNX1-AS1 Drives the Progression in Lung Cancer.
Lv D, Wang Y, Li S, Shao X, Jin Q. | 01/28/2023 |
| MNX1-AS1, a c-Myc induced lncRNA, promotes the Warburg effect by regulating PKM2 nuclear translocation. | MNX1-AS1, a c-Myc induced lncRNA, promotes the Warburg effect by regulating PKM2 nuclear translocation.
Wu Y, Wang Y, Yao H, Li H, Meng F, Li Q, Lin X, Liu L., Free PMC Article | 12/17/2022 |
| LncRNA MNX1-AS1 sustains inactivation of Hippo pathway through a positive feedback loop with USP16/IGF2BP3 axis in gallbladder cancer. | LncRNA MNX1-AS1 sustains inactivation of Hippo pathway through a positive feedback loop with USP16/IGF2BP3 axis in gallbladder cancer.
Liu S, Li H, Zhu Y, Ma X, Shao Z, Yang Z, Cai C, Wu Z, Li M, Gong W, Wu X. | 09/24/2022 |
| Comprehensive network analysis of dysregulated genes revealed MNX1-AS1/hsa-miR-4697-3p/HOXB13 axis in ovarian cancer chemotherapy response. | Comprehensive network analysis of dysregulated genes revealed MNX1-AS1/hsa-miR-4697-3p/HOXB13 axis in ovarian cancer chemotherapy response.
Wu A, Liu J, Zhang X, Niu C, Shu G, Yin G., Free PMC Article | 08/13/2022 |
| lncRNA MNX1AS1 promotes prostate cancer progression through regulating miR2113/MDM2 axis. | lncRNA MNX1‑AS1 promotes prostate cancer progression through regulating miR‑2113/MDM2 axis.
Liang D, Tian C, Zhang X., Free PMC Article | 08/6/2022 |
| LncRNA MNX1-AS1: A novel oncogenic propellant in cancers. | LncRNA MNX1-AS1: A novel oncogenic propellant in cancers.
Li T, Zhou S, Yang Y, Xu Y, Gong X, Cheng Y, Wang Y. | 04/30/2022 |
| Actinidia chinensis Planch Root extract suppresses the growth and metastasis of hypopharyngeal carcinoma by inhibiting E2F Transcription Factor 1-mediated MNX1 antisense RNA 1. | Actinidia chinensis Planch Root extract suppresses the growth and metastasis of hypopharyngeal carcinoma by inhibiting E2F Transcription Factor 1-mediated MNX1 antisense RNA 1.
Zheng Y, Su L, Tan J, Dong F., Free PMC Article | 04/16/2022 |
| LncRNA MNX1-AS1 promotes ovarian cancer process via targeting the miR-744-5p/SOX12 axis. | LncRNA MNX1-AS1 promotes ovarian cancer process via targeting the miR-744-5p/SOX12 axis.
Shen Y, Lv M, Fang Y, Lu J, Wu Y., Free PMC Article | 02/19/2022 |
| Clinical significance of long noncoding RNA MNX1-AS1 in human cancers: a meta-analysis of cohort studies and bioinformatics analysis based on TCGA datasets. | Clinical significance of long noncoding RNA MNX1-AS1 in human cancers: a meta-analysis of cohort studies and bioinformatics analysis based on TCGA datasets.
Chen K, Gan JX, Huang ZP, Liu J, Liu HP., Free PMC Article | 11/22/2021 |
| MYC-Activated LncRNA MNX1-AS1 Promotes the Progression of Colorectal Cancer by Stabilizing YB1. | MYC-Activated LncRNA MNX1-AS1 Promotes the Progression of Colorectal Cancer by Stabilizing YB1.
Wu QN, Luo XJ, Liu J, Lu YX, Wang Y, Qi J, Liu ZX, Huang QT, Liu ZK, Lu JB, Jin Y, Pu HY, Hu PS, Zheng JB, Zeng ZL, Ju HQ, Xie D, Zhao Q, Xu R. | 11/13/2021 |
| LncRNA MNX1-AS1 promotes progression of intrahepatic cholangiocarcinoma through the MNX1/Hippo axis. | LncRNA MNX1-AS1 promotes progression of intrahepatic cholangiocarcinoma through the MNX1/Hippo axis.
Li F, Chen Q, Xue H, Zhang L, Wang K, Shen F., Free PMC Article | 04/13/2021 |
| TEAD4 modulated LncRNA MNX1-AS1 contributes to gastric cancer progression partly through suppressing BTG2 and activating BCL2. | TEAD4 modulated LncRNA MNX1-AS1 contributes to gastric cancer progression partly through suppressing BTG2 and activating BCL2.
Shuai Y, Ma Z, Liu W, Yu T, Yan C, Jiang H, Tian S, Xu T, Shu Y., Free PMC Article | 01/16/2021 |
| Long noncoding RNA MNX1-AS1 overexpression promotes the invasion and metastasis of gastric cancer through repressing CDKN1A. | Long noncoding RNA MNX1-AS1 overexpression promotes the invasion and metastasis of gastric cancer through repressing CDKN1A.
Ma JX, Yang YL, He XY, Pan XM, Wang Z, Qian YW. | 10/3/2020 |
| Data concluded that E2F1-mediated MNX1-AS1-miR-218-5p-SEC61A1 feedback loop contributed to the progression of colon adenocarcinoma. | E2F1-mediated MNX1-AS1-miR-218-5p-SEC61A1 feedback loop contributes to the progression of colon adenocarcinoma.
Ye Y, Gu B, Wang Y, Shen S, Huang W. | 07/25/2020 |
| MNX1-AS1 promoted COMMD8 expression through sponging miR-218-5p. MNX1-AS1 promoted hepatocellular carcinoma progression through activating COMMD8. | Long non-coding RNA MNX1-AS1 promotes hepatocellular carcinoma proliferation and invasion through targeting miR-218-5p/COMMD8 axis.
Ji D, Wang Y, Sun B, Yang J, Luo X. | 06/27/2020 |
| This study found a novel signaling pathway, namely MNX1-AS1/miR-527/BRF2 axis, involved in lung cancer progression. | Long noncoding RNA MNX1-AS1 contributes to lung cancer progression through the miR-527/BRF2 pathway.
Liu H, Han L, Liu Z, Gao N. | 05/23/2020 |
| MNX1-AS1 promoted proliferation and inhibited apoptosis of cervical cancer cells through MAPK pathway. Expression of MNX1-AS1 is upregulated in cervical cancer tissues and cell lines and correlate with poor prognosis. | LncRNA MNX1-AS1 promotes the progression of cervical cancer through activating MAPK pathway.
Liu X, Yang Q, Yan J, Zhang X, Zheng M. | 04/11/2020 |
| Long noncoding RNA MNX1-AS1/miR-34a/SIRT1 regulatory axis could play an important role in esophageal squamous cell carcinoma progression. | LncRNA MNX1-AS1 promotes progression of esophageal squamous cell carcinoma by regulating miR-34a/SIRT1 axis.
Chu J, Li H, Xing Y, Jia J, Sheng J, Yang L, Sun K, Qu Y, Zhang Y, Yin H, Wan J, He F. | 01/18/2020 |
| FIGO stage, distant metastasis, and MNX1-AS1 expression were independent prognostic factors of both overall survival and progression-free survival for patients with epithelial ovarian cancer. | Overexpression of lncRNA MNX1-AS1 is associated with poor clinical outcome in epithelial ovarian cancer.
Li AH, Zhang HH. | 08/24/2019 |